echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Remidazolam besylate, a new anesthetic drug of humanwell pharmaceutical, 1.1, has been successfully approved

    Remidazolam besylate, a new anesthetic drug of humanwell pharmaceutical, 1.1, has been successfully approved

    • Last Update: 2015-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the information on June 17 on the website of the State Food and Drug Administration (CFDA), the acceptance status of humanwell Pharmaceutical (600079) class 1.1 new drug rimazazolam besylate and rimazazolam besylate for injection was changed to "certificate preparation completed - pending approval document", or clinical approval was successfully obtained Yichang humanwell insiders told the big smart news agency that the company has not yet received the approval, but the approval is basically OK After receiving the approval, organize the next work as soon as possible It is understood that remazolam benzenesulfonate of Yichang humanwell Pharmaceutical (600079), a holding subsidiary of humanwell, is used for surgical anesthesia Yichang humanwell has undertaken the R & D, production and sales of humanwell Pharmaceutical (600079) narcotic analgesics In 2014, the sales revenue of humanwell Yichang was 1528652500 yuan, accounting for 21.68% of the business revenue According to some data, in 2013, the market scale of anesthetics in sample hospitals in 16 cities in China reached 1.4 billion yuan, an increase of 8.31% over the previous year, and the anesthesia industry has maintained a high compound growth rate in the past few years In the field of anesthetics, it is divided into intravenous injection and inhalation type according to the way of administration Intravenous injection is mainly used in China and Europe, while inhalation type is mainly used in North America Humanwell Pharmaceutical (600079) is mainly engaged in the pharmaceutical industry, and its market segments include anesthetics, analgesics, birth control drugs, blood products, Uygur nationality drugs, etc In the field of narcotic drugs in China, humanwell Pharmaceutical (600079) is a leading enterprise, and its market share of narcotic drugs ranks first in China.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.